MED Medifast
Price Chart
Executive Summary
Medifast (MED) issued a press release highlighting OPTAVIA's clinical research portfolio, including 18 randomized controlled trials and a study showing 98% lean mass preservation. The release is promotional and lacks new financial data or material corporate events, making it a routine brand-building communication with no immediate stock-moving impact.
Actionable Insight
This press release contains no new financial data, guidance, or material corporate developments. It is a routine brand-building communication. No trading action is warranted based on this filing.
Key Facts
- OPTAVIA's research portfolio includes 18 randomized controlled trials and 100+ peer-reviewed presentations/publications.
- A 16-week RCT found OPTAVIA Optimal Weight 5 & 1 Plan preserved 98% of lean mass.
- Clients with coaching lost up to 10x more weight and 17x more fat than those without coaching.
- No new financial results, guidance, or material corporate events were disclosed.
Financial Impact
No financial impact; press release is a marketing summary of existing clinical data.
Risk Factors
- Press release may be viewed as a defensive response to competition from GLP-1 drugs, but no concrete strategy changes were announced.
- No new financial data means no catalyst for near-term stock movement.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296057 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
8-K
| $12.70 $12.10 | ▼ −4.72% | ▼ −1.97% | $12.07 (−4.96%) |
|
May 26, 2026
14d ago
|
8-K
| $12.72 $12.36 | ▼ −2.83% | ▼ −4.04% | $12.07 (−5.11%) |
|
May 21, 2026
19d ago
|
Press Release
| $12.63 $12.53 | ▼ −0.79% | ▼ −2.64% | $12.07 (−4.43%) |
|
May 21, 2026
19d ago
|
Press Release
| $12.63 $12.53 | ▼ −0.79% | ▼ −2.64% | $12.07 (−4.43%) |
|
May 15, 2026
25d ago
|
Press Release
| $12.48 $12.59 | ▲ +0.88% | ▼ −0.08% | $12.07 (−3.29%) |
|
May 15, 2026
25d ago
|
Press Release
| $12.48 $12.59 | ▲ +0.88% | ▼ −0.08% | $12.07 (−3.29%) |
|
May 4, 2026
5w ago
|
8-K
| $13.02 $12.57 | ▲ +3.46% | ▲ +5.44% | $12.07 (+7.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access